Table 1.
Characteristic | Patients (N = 108) |
---|---|
Sex | |
Male – no. (%) | 65 (60.2%) |
Female – no. (%) | 43 (39.8%) |
Age | |
Median, y | 6 y 7 months |
Range, y | 5 months–18 y 7 months |
WHO grading | |
Grade II | 14 (13%) |
Grade III | 73 (67.6%) |
unknown | 21 (19.4%) |
Extent of surgical resection | |
Gross total resection (GTR) | 84 (77.8%) |
Subtotal resection (STR) | 24 (22.2%) |
Radiotherapy | |
Yes | 98 (90.7%) |
No | 10 (9.3%) |
Chemotherapy | |
Yes | 63 (58.3%) |
E-HIT Stratum A | 29 (26.9%) |
E-HIT Stratum B | 16 (14.8%) |
E-HIT Stratum C | 4 (3.7%) |
ACNS 0831 | 5 (4.6%) |
ICE | 3 (2.8%) |
Personalized treatment | 2 (1.9%) |
HIT 91 | 1 (0.9%) |
CCLG 2007 | 1 (0.9%) |
SIOP ependymoma II | 1 (0.9%) |
No | 45 (41.7%) |
Relapse/recurrence disease | |
Local | 21 (19.4%) |
Distant | 3 (2.8%) |
Combined local/distant | 1 (0.9%) |
Unknown | 14 (13%) |